Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1035, pseudogene (RNU6-1035P) is a member of the large family of U6 small nuclear RNA pseudogenes found in the human genome[5][1]. U6 snRNA is an essential component of the spliceosomal complex, but RNU6-1035P is classified as a pseudogene, meaning it represents a non-functional genomic relic derived from the U6 snRNA gene. Pseudogenes such as RNU6-1035P do not encode a functional RNA or protein product and generally lack biological activity. While there is emerging evidence that some pseudogenes can possess regulatory roles at the RNA level, notably by acting as miRNA sponges or competing endogenous RNAs in certain cellular contexts[2], there is no documented functional or therapeutic role for this specific pseudogene. It is important to note that pseudogenes are typically not considered therapeutic targets, receptors, enzymes, or otherwise active molecules. The presence of this designation in any therapeutic target database would usually indicate an error or misclassification. Key Notes: - The name refers specifically to a pseudogene copy of the U6 small nuclear RNA gene and not the functional U6 snRNA itself[1][3][5]. - Pseudogenes may sometimes be investigated in large-scale RNA-seq or genome annotation studies but are not actionable drug targets[2]. - No role of RNU6-1035P as a biomarker, therapeutic target, or disease driver has been described in the scientific literature (as of the current date). - Including this pseudogene in a list of protein, receptor, transporter, or enzyme targets would be incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1035, pseudogene (RNU6-1035P).